Epigenetics in Gastric Carcinogenesis: Tet Genes as Important Players

REFERENCES

• McLean, M.H.; El-Omar, E.M. Genetics of Gastric Cancer. Nat. Rev. Gastroenterol. Hepatol. 2014, 11(11), 664–674.
   PubMed Web of Science ®Google Scholar
• Wu, P.Y.; Zhang, Z.; Wang, J.M.; Guo, W.W.; Xiao, N.; He, Q.; Wang, Y.P.; Fan, Y.M. Germline Promoter Hypermethylation of Tumor Suppressor Genes in Gastric Cancer. World J. Gastroenterol. 2012, 18(1), 70–78.
   PubMed Web of Science ®Google Scholar
• Ben Ayed-Guerfali, D.; Benhaj, K.; Khabir, A.; Abid, M.; Bayrouti, M.I.; Sellami-Boudawara, T.; Gargouri, A.; Mokdad-Gargouri, R. Hypermethylation of Tumor-Related Genes in Tunisian Patients with Gastric Carcinoma: Clinical and Biological Significance. J. Surg. Oncol. 2011, 103(7), 687–694.
   PubMed Web of Science ®Google Scholar
• do Nascimento Borges, B.; Burbano, R.M.; Harada, M.L. Analysis of the Methylation Patterns of the p16 INK4A, p15 INK4B, and APC Genes in Gastric Adenocarcinoma Patients from a Brazilian Population. Tumour Biol. 2013, 34(4), 2127–2133.
   PubMed Web of Science ®Google Scholar
• Matsusaka, K.; Funata, S.; Fukayama, M.; Kaneda, A. DNA Methylation in Gastric Cancer, Related to Helicobacter Pylori and Epstein-Barr Virus. World J. Gastroenterol. 2014, 20(14), 3916–3926.
   PubMed Web of Science ®Google Scholar
• Matsusaka, K.; Kaneda, A.; Nagae, G.; Ushiku, T.; Kikuchi, Y.; Hino, R.; Uozaki, H.; Seto, Y.; Takada, K.; Aburatani, H.; Fukayama, M. Classification of Epstein-Barr Virus-Positive Gastric Cancers by Definition of DNA Methylation Epigenotypes. Cancer Res. 2011, 71(23), 7187–7197.
   PubMed Web of Science ®Google Scholar
• Wang, F.; Meng, W.; Wang, B.; Qiao, L. Helicobacter Pylori-Induced Gastric Inflammation and Gastric Cancer. Cancer Lett. 2014, 345(2), 196–202.
   PubMed Web of Science ®Google Scholar
• Ushijima, T.; Nakajima, T.; Maekita, T. DNA Methylation as a Marker for the Past and Future. J. Gastroenterol. 2006, 41(5), 401–407.
   PubMed Web of Science ®Google Scholar
• Shin, C. M.; Kim, N.; Jung, Y.; Park, J. H.; Kang, G. H.; Kim, J. S.; Jung, H. C.; Song, I. S. Role of Helicobacter Pylori Infection in Aberrant DNA Methylation along Multistep Gastric Carcinogenesis. Cancer Sci. 2010, 101(6), 1337–1346.
   PubMed Web of Science ®Google Scholar
• Kang, G.H.; Shim, Y.H.; Jung, H.Y.; Kim, W.H.; Ro, J.Y.; Rhyu, M.G. CpG Island Methylation in Premalignant Stages of Gastric Carcinoma. Cancer Res. 2001, 61(7), 2847–2851.
   PubMed Web of Science ®Google Scholar
• Dumitrescu, R.G. Epigenetic Markers of Early Tumor Development. Meth. Mol. Biol. 2012, 863, 3–14.
   PubMedGoogle Scholar
• Zhao, Y.; Zhou, H.; Ma, K.; Sun, J.; Feng, X.; Geng, J.; Gu, J.; Wang, W.; Zhang, H.; He, Y.; Guo, S.; Zhou, X.; Yu, J.; Lin, Q. Abnormal Methylation of Seven Genes and Their Associations with Clinical Characteristics in Early Stage Non-Small Cell Lung Cancer. Oncol. Lett. 2013, 5(4), 1211–1218.
   PubMed Web of Science ®Google Scholar
• Yakirevich, E.; Resnick, M.B. Pathology of Gastric Cancer and its Precursor Lesions. Gastroenterol. Clin. North Am. 2013, 42(2), 261–284.
   PubMed Web of Science ®Google Scholar
• Qu, Y.; Dang, S.; Hou, P. Gene Methylation in Gastric Cancer. Clin. Chim. Acta. 2013, 424, 53–65.
   PubMed Web of Science ®Google Scholar
• Ichikawa, D.; Koike, H.; Ikoma, H.; Ikoma, D.; Tani, N.; Otsuji, E.; Kitamura, K.; Yamagishi, H. Detection of Aberrant Methylation as a Tumor Marker in Serum of Patients with Gastric Cancer. Anticancer Res. 2004, 24(4), 2477–2481.
   PubMed Web of Science ®Google Scholar
• Lu, X.X.; Yu, J.L.; Ying, L.S.; Han, J.; Wang, S.; Yu, Q.M.; Wang, X.B.; Fang, X.H.; Ling, Z.Q. Stepwise Cumulation of RUNX3 Methylation Mediated by Helicobacter Pylori Infection Contributes to Gastric Carcinoma Progression. Cancer 2012, 118(22), 5507–5517.
   PubMed Web of Science ®Google Scholar
• Wu, H.; Zhang, Y. Mechanisms and Functions of Tet Protein-Mediated 5-Methylcytosine Oxidation. Genes Dev. 2011, 25(23), 2436–2452.
   PubMed Web of Science ®Google Scholar
• Williams, K.; Christensen, J.; Helin, K. DNA Methylation: TET Proteins-Guardians of CpG Islands? EMBO Rep. 2012, 13(1), 28–35.
   Web of Science ®Google Scholar
• Szwagierczak, A.; Bultmann, S.; Schmidt, C.S.; Spada, F.; Leonhardt, H. Sensitive Enzymatic Quantification of 5-hydroxymethylcytosine in Genomic DNA. Nucleic Acids Res. 2010, 38(19), e181.
   PubMed Web of Science ®Google Scholar
• Tahiliani, M.; Koh, K.P.; Shen, Y.; Pastor, W.A.; Bandukwala, H.; Brudno, Y.; Agarwal, S.; Iyer, L.M.; Liu, D.R.; Aravind, L.; Rao, A. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1. Science. 2009, 324(5929), 930–935.
   PubMed Web of Science ®Google Scholar
• Ono, R.; Taki, T.; Taketani, T.; Taniwaki, M.; Kobayashi, H.; Hayashi, Y. LCX, Leukemia-Associated Protein with a CXXC Domain, is Fused to MLL in Acute Myeloid Leukemia with Trilineage Dysplasia Having t(10;11)(q22;q23). Cancer Res. 2002, 62(14), 4075–4080.
   PubMed Web of Science ®Google Scholar
• Lorsbach, R.B.; Moore, J.; Mathew, S.; Raimondi, S.C.; Mukatira, S.T.; Downing, J.R. TET1, a Member of a Novel Protein Family, is Fused to MLL in Acute Myeloid Leukemia Containing the t(10;11)(q22;q23). Leukemia 2003, 17(3), 637–641.
   PubMed Web of Science ®Google Scholar
• Jankowska, A.M.; Szpurka, H.; Tiu, R.V.; Makishima, H.; Afable, M.; Huh, J.; O’Keefe, C.L.; Ganetzky, R.; McDevitt, M.A.; Maciejewski, J.P. Loss of Heterozygosity 4q24 and TET2 Mutations Associated with Myelodysplastic/Myeloproliferative Neoplasms. Blood 2009, 113(25), 6403–6410.
   PubMed Web of Science ®Google Scholar
• Ito, S.; D’Alessio, A.C.; Taranova, O.V.; Hong, K.; Sowers, L.C.; Zhang, Y. Role of Tet Proteins in 5mC to 5hmC Conversion, ES-Cell Self-Renewal and Inner Cell Mass Specification. Nature 2010, 466(7310), 1129–1133.
   PubMed Web of Science ®Google Scholar
• Abdel-Wahab, O.; Mullally, A.; Hedvat, C.; Garcia-Manero, G.; Patel, J.; Wadleigh, M.; Malinge, S.; Yao, J.; Kilpivaara, O.; Bhat, R.; Huberman, K.; Thomas, S.; Dolgalev, I.; Heguy, A.; Paietta, E.; Le Beau, M.M.; Beran, M.; Tallman, M.S.; Ebert, B.L.; Kantarjian, H.M.; Stone, R.M.; Gilliland, D.G.; Crispino, J.D.; Levine, R.L. Genetic Characterization of TET1, TET2, and TET3 Alterations in Myeloid Malignancies. Blood 2009, 114(1), 144–147.
   PubMed Web of Science ®Google Scholar
• Pronier, E.; Delhommeau, F. Role of TET2 Mutations in Myeloproliferative Neoplasms. Curr Hematol Malig Rep. 2012, 7(1), 57–64.
   PubMedGoogle Scholar
• Huang, Y.; Rao, A. Connections between TET Proteins and Aberrant DNA Modification in Cancer. Trends Genet. 2014, 30(10), 464–474.
   PubMed Web of Science ®Google Scholar
• Yang, H.; Liu, Y.; Bai, F.; Zhang, J.Y.; Ma, S.H.; Liu, J.; Xu, Z.D.; Zhu, H.G.; Ling, Z.Q.; Ye, D.; Guan, K.L.; Xiong, Y. Tumor Development is Associated with Decrease of TET gene expression and 5-methylcytosine hydroxylation. Oncogene 2013, 32(5), 663–669.
   PubMed Web of Science ®Google Scholar
• Rawluszko-Wieczorek, A.A.; Siera, A.; Horbacka, K.; Horst, N.; Krokowicz, P.; Jagodzinski, P.P. Clinical Significance of DNA Methylation mRNA Levels of TET Family Members in Colorectal Cancer. J. Cancer Res. Clin. Oncol. 2015, PMID: 25557833 [Epub ahead of print].
   Google Scholar
• Chim, C.S.; Wan, T.S.; Fung, T.K.; Wong, K.F. Methylation of TET2, CBL and CEBPA in Ph-Negative Myeloproliferative Neoplasms. J. Clin. Pathol. 2010, 63(10), 942–946.
   PubMed Web of Science ®Google Scholar
• Kim, Y.H.; Pierscianek, D.; Mittelbronn, M.; Vital, A.; Mariani, L.; Hasselblatt, M.; Ohgaki, H. TET2 Promoter Methylation in Low-Grade Diffuse Gliomas Lacking IDH1/2 Mutations. J. Clin. Pathol. 2011, 64(10), 850–852.
   PubMed Web of Science ®Google Scholar
• Nakagawa, T.; Lv, L.; Nakagawa, M.; Yu, Y.; Yu, C.; D’Alessio, A.C.; Nakayama, K.; Fan, H.Y.; Chen, X.; Xiong, Y. CRL4(VprBP) E3 Ligase Promotes Monoubiquitylation and Chromatin Binding of TET Dioxygenases. Mol. Cell. 2015, 57(2), 247–260.
   PubMed Web of Science ®Google Scholar
• Ciccarone, F.; Valentini, E.; Bacalini, M.G.; Zampieri, M.; Calabrese, R.; Guastafierro, T.; Mariano, G.; Reale, A.; Franceschi, C.; Caiafa, P. Poly(ADP-ribosyl)ation is Involved in the Epigenetic Control of TET1 Gene Transcription. Oncotarget 2014, 5(21), 10356–10367.
   PubMedGoogle Scholar
• Du, C.; Kurabe, N.; Matsushima, Y.; Suzuki, M.; Kahyo, T.; Ohnishi, I.; Tanioka, F.; Tajima, S.; Goto, M.; Yamada, H.; Tao, H.; Shinmura, K.; Konno, H.; Sugimura, H. Robust Quantitative Assessments of Cytosine Modifications and Changes in the Expressions of Related Enzymes in Gastric Cancer. Gastric Cancer. 2014, PMID: 25098926 [Epub ahead of print].
   Google Scholar
• Yang, Q.; Wu, K.; Ji, M.; Jin, W.; He, N.; Shi, B.; Hou, P. Decreased 5-Hydroxymethylcytosine (5-hmC) is an Independent Poor Prognostic Factor in Gastric Cancer Patients. J. Biomed. Nanotechnol. 2013, 9(9), 1607–1616.
   PubMed Web of Science ®Google Scholar
• Frycz, B.A.; Murawa, D.; Borejsza-Wysocki, M.; Marciniak, R.; Murawa, P.; Drews, M.; Kolodziejczak, A.; Tomela, K.; Jagodzinski, P. P. Decreased Expression of Ten-Eleven Translocation 1 Protein is Associated with Some Clinicopathological Features in Gastric Cancer. Biomed. Pharmacother. 2014, 68(2), 209–212.
   PubMed Web of Science ®Google Scholar
• Park, J.-L.; Kwon, O.-H.; Song, K. S.; Kim, S.-Y.; Kim, Y.S. Abstract 394: TET1, which Act as an Tumor Suppressor Gene, is Suppressed by DNA Hypermethylation in Gastric Cancer. Cancer Res. 2014, 74 (19 Supplement), 394.
   Google Scholar
• Matkar, S.S.; Durham, A.; Brice, A.; Wang, T.C.; Rustgi, A.K.; Hua, X. Systemic Activation of K-ras Rapidly Induces Gastric Hyperplasia and Metaplasia in Mice. Am. J. Cancer Res. 2011, 1(4), 432–445.
   Web of Science ®Google Scholar
• Wu, B.K.; Brenner, C. Suppression of TET1-Dependent DNA Demethylation Is Essential for KRAS-Mediated Transformation. Cell Rep. 2014, 9(5), 1827–1840.
   PubMed Web of Science ®Google Scholar
• Yu, J.; Tao, Q.; Cheng, Y.Y.; Lee, K.Y.; Ng, S.S.; Cheung, K. F.; Tian, L.; Rha, S.Y.; Neumann, U.; Rocken, C.; Ebert, M.P.; Chan, F.K.; Sung, J.J. Promoter Methylation of the Wnt/Beta-Catenin Signaling Antagonist Dkk-3 is Associated with Poor Survival in Gastric Cancer. Cancer. 2009, 115(1), 49–60.
   PubMed Web of Science ®Google Scholar
• Neri, F.; Dettori, D.; Incarnato, D.; Krepelova, A.; Rapelli, S.; Maldotti, M.; Parlato, C.; Paliogiannis, P.; Oliviero, S. TET1 is a Tumour Suppressor that Inhibits Colon Cancer Growth by Derepressing Inhibitors of the WNT Pathway. Oncogene 2014, doi:10.1038/onc.2014.356. [Epub ahead of print].
   PubMedGoogle Scholar
• Zha, L.; Zhang, J.; Tang, W.; Zhang, N.; He, M.; Guo, Y.; Wang, Z. HMGA2 Elicits EMT by Activating the Wnt/Beta-Catenin Pathway in Gastric Cancer. Dig. Dis. Sci. 2013, 58(3), 724–733.
   PubMed Web of Science ®Google Scholar
• Sun, M.; Song, C.X.; Huang, H.; Frankenberger, C.A.; Sankarasharma, D.; Gomes, S.; Chen, P.; Chen, J.; Chada, K.K.; He, C.; Rosner, M.R. HMGA2/TET1/HOXA9 Signaling Pathway Regulates Breast Cancer Growth and Metastasis. Proc. Natl. Acad. Sci. USA 2013, 110(24), 9920–9925.
   PubMed Web of Science ®Google Scholar
• Fu, H.L.; Ma, Y.; Lu, L.G.; Hou, P.; Li, B.J.; Jin, W.L.; Cui, D.X. TET1 Exerts its Tumor Suppressor Function by Interacting with p53-EZH2 Pathway in Gastric Cancer. J. Biomed. Nanotechnol. 2014, 10(7), 1217–1230.
   PubMed Web of Science ®Google Scholar
• Hsu, C.H.; Peng, K.L.; Kang, M.L.; Chen, Y.R.; Yang, Y.C.; Tsai, C.H.; Chu, C.S.; Jeng, Y.M.; Chen, Y.T.; Lin, F.M.; Huang, H.D.; Lu, Y.Y.; Teng, Y.C.; Lin, S.T.; Lin, R.K.; Tang, F.M.; Lee, S.B.; Hsu, H.M.; Yu, J.C.; Hsiao, P. W.; Juan, L. J. TET1 Suppresses Cancer Invasion by Activating the Tissue Inhibitors of Metalloproteinases. Cell Rep. 2012, 2(3), 568–579.
   PubMed Web of Science ®Google Scholar
• Gu, P.; Xing, X.; Tanzer, M.; Rocken, C.; Weichert, W.; Ivanauskas, A.; Pross, M.; Peitz, U.; Malfertheiner, P.; Schmid, R.M.; Ebert, M.P. Frequent Loss of TIMP-3 Expression in Progression of Esophageal and Gastric Adenocarcinomas. Neoplasia 2008, 10(6), 563–572.
   PubMed Web of Science ®Google Scholar
• Chen, J.; Chen, L.J.; Zhou, H.C.; Yang, R.B.; Lu, Y.; Xia, Y.L.; Wu, W.; Hu, L.W. Prognostic Value of Matrix Metalloproteinase-9 in Gastric Cancer: A Meta-Analysis. Hepatogastroenterology 2014, 61(130), 518–524.
   PubMed Web of Science ®Google Scholar
• Sentani, K.; Matsuda, M.; Oue, N.; Uraoka, N.; Naito, Y.; Sakamoto, N.; Yasui, W. Clinicopathological Significance of MMP-7, Laminin Gamma2 and EGFR Expression at the Invasive Front of Gastric Carcinoma. Gastric Cancer. 2014, 17(3), 412–422.
   PubMed Web of Science ®Google Scholar
• Kosaka, Y.; Mimori, K.; Fukagawa, T.; Ishikawa, K.; Etoh, T.; Katai, H.; Sano, T.; Watanabe, M.; Sasako, M.; Mori, M. Clinical Significance of Molecular Detection of Matrix Metalloproteinase-1 in Bone Marrow and Peripheral Blood in Patients with Gastric Cancer. Ann Surg Oncol. 2012, 19 Suppl 3, S430–437.
   PubMed Web of Science ®Google Scholar
• Ye, D.; Ma, S.; Xiong, Y.; Guan, K. L. R-2-hydroxyglutarate as the Key Effector of IDH Mutations Promoting Oncogenesis. Cancer Cell. 2013, 23(3), 274–276.
   PubMed Web of Science ®Google Scholar
• Yin, R.; Mao, S.Q.; Zhao, B.; Chong, Z.; Yang, Y.; Zhao, C.; Zhang, D.; Huang, H.; Gao, J.; Li, Z.; Jiao, Y.; Li, C.; Liu, S.; Wu, D.; Gu, W.; Yang, Y.G.; Xu, G.L.; Wang, H. Ascorbic Acid Enhances Tet-Mediated 5-methylcytosine Oxidation and Promotes DNA Demethylation in Mammals. J. Am. Chem. Soc. 2013, 135(28), 10396–10403.
   PubMed Web of Science ®Google Scholar
• Hassan, Z.K.; Daghestani, M.H. Curcumin Effect on MMPs and TIMPs Genes in a Breast Cancer Cell Line. Asian Pac. J. Cancer Prev. 2012, 13(7), 3259–3264.
   PubMed Web of Science ®Google Scholar
• Jones, P.A. At the Tipping Point for Epigenetic Therapies in Cancer. J. Clin. Invest. 2014, 124(1), 14–16.
   PubMed Web of Science ®Google Scholar
• Niwa, T.; Toyoda, T.; Tsukamoto, T.; Mori, A.; Tatematsu, M.; Ushijima, T. Prevention of Helicobacter Pylori-Induced Gastric Cancers in Gerbils by a DNA Demethylating Agent. Cancer Prev, Res, (Phila.) 2013, 6(4), 263–270.
   PubMed Web of Science ®Google Scholar